In research by Ruiz-Litago et al., it was observed that the plasmatic levels of SOD in first-episode schizophrenia patients decreased significantly after one month and remained at a low level even after the 6-month follow-up period compared to the baseline measurement, which indicates an altered antioxidant defense at the onset of psychosis [14]. This evidence concerns the gene SOD1 and psychotic disorder.